PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

For the first time in 40 Years, Panama’s deep and cold ocean waters failed to emerge, possibly affecting fisheries and coral health

2025-09-01
(Press-News.org) During the dry season in Central America (generally between December and April), northern trade winds generate upwelling events in the ocean waters of the Gulf of Panama. Upwelling is a process that allows cold, nutrient-rich waters from the depths of the ocean to rise to the surface. This dynamic supports highly productive fisheries and helps protect coral reefs from thermal stress. Thanks to this movement of water, the sea along Panama’s Pacific beaches remains cooler during the "summer" vacation season.

Scientists from the Smithsonian Tropical Research Institute (STRI) have studied this phenomenon and their records show that this seasonal upwelling, which occurs from January to April, has been a consistent and predictable feature of the gulf for at least 40 years. However, researchers recently recorded that in 2025, this vital oceanographic process did not occur for the first time. As a result, the typical drops in temperature and spikes in productivity during this time of year were diminished. In the recently published article in the journal PNAS, scientists suggest that a significant reduction in wind patterns was the cause of this unprecedented event, revealing how climate disruption can quickly alter fundamental oceanic processes that have sustained coastal fishing communities for thousands of years. Still, further research is needed to determine a more precise cause and its potential consequences for fisheries.

This finding highlights the growing vulnerability of tropical upwelling systems, which, despite their enormous ecological and socioeconomic importance, remain poorly monitored. It also underscores the urgency of strengthening ocean-climate observation and prediction capabilities in the planet’s tropical regions.

This result marks one of the first major outcomes of the collaboration between the S/Y Eugen Seibold research vessel from the Max Planck Institute and STRI.

Reference: O’Dea, A., Sellers, A. J., Pérez-Medina, C., Pardo Díaz, J., Guzmán Bloise, A., Pöhlker, C., Chiliński, M. T., Aardema, H. M., Cybulski, J. D., Heins, L., Paton, S. R., Slagter, H. A., Schiebel, R., & Haug, G. H. 2025. Unprecedented suppression of Panama's Pacific upwelling in 2025. Proceedings of the National Academy of Sciences: Issue: Vol. 122, Iss. 0). DOI: 10.1073/pnas.2512056122

 

About the Smithsonian Tropical Research Institute

Headquartered in Panama City, Panama, STRI is a unit of the Smithsonian Institution. Our mission is to understand tropical biodiversity and its importance to human welfare, to train students to conduct research in the tropics and to promote conservation by increasing public awareness of the beauty and importance of tropical ecosystems. Watch our video, and visit our website, Facebook, X and Instagram for updates.

END


ELSE PRESS RELEASES FROM THIS DATE:

Depression may make learning to avoid unpleasant events harder

2025-09-01
Depression alters how people pursue rewards, but, conversely, whether depressive symptoms influence how people learn to avoid nonrewarding, unpleasant events is less clear. Ryan Tomm and colleagues, from the University of British Colombia, addressed this question in their eNeuro paper to shed more light on the relationship between depression and learning. This work brought together researchers from preclinical, cognitive, and clinical backgrounds, building stronger connections across fields to better understand the mechanisms of depression.    The researchers developed a behavioral task for study volunteers based off rodent research ...

Study sheds light on how pediatric brain tumors grow

2025-09-01
The most common type of brain tumor in children, pilocytic astrocytoma (PA), accounts for about 15% of all pediatric brain tumors. Although this type of tumor is usually not life-threatening, the unchecked growth of tumor cells can disrupt normal brain development and function. Current treatments focus mainly on removing the tumor cells, but recent studies have shown that non-cancerous cells, such as nerve cells, also play a role in brain tumor formation and growth, suggesting novel approaches to treating these cancers. Scientists have long known that a nerve cell signaling chemical called glutamate can increase growth of cancers throughout the body, but despite ...

Rare seasonal brain shrinkage in shrews is driven by water loss, not cell death

2025-09-01
Common shrews are one of only a handful of mammals known to flexibly shrink and regrow their brains. This rare seasonal cycle, known as Dehnel’s phenomenon, has puzzled scientists for decades. How can a brain lose volume and regrow months later without sustaining permanent damage? A study using non-invasive MRI has scanned the brains of shrews undergoing shrinkage, identifying a key molecule involved in the phenomenon: water. “Our shrews lost nine percent of their brains during shrinkage, but the cells did not die,” says first author Dr. Cecilia Baldoni, a postdoctoral researcher from the Max Planck Institute of Animal Behavior ...

AI co-pilot boosts noninvasive brain-computer interface by interpreting user intent

2025-09-01
UCLA engineers have developed a wearable, noninvasive brain-computer interface system that utilizes artificial intelligence as a co-pilot to help infer user intent and complete tasks by moving a robotic arm or a computer cursor. Published in Nature Machine Intelligence, the study shows that the interface demonstrates a new level of performance in noninvasive brain-computer interface, or BCI, systems. This could lead to a range of technologies to help people with limited physical capabilities, such as those with paralysis or neurological conditions, handle and move objects more easily and precisely. The team developed custom algorithms to decode electroencephalography, or EEG — ...

Black adults face heart failure nearly 14 years earlier than white patients

2025-09-01
Black adults first hospitalized for heart failure in the U.S. at age 60.1, vs. 73.6 for white adults Hispanic patients first hospitalized at 65.4; Asian American patients at 70.6 CHICAGO --- Black adults in the U.S. are first hospitalized for heart failure nearly 14 years earlier than white adults, reports a Northwestern Medicine study that analyzed data from more than 42,000 patients across hundreds of hospitals nationwide. The study also found that Hispanic patients were hospitalized about eight years earlier than white patients, and Asian patients about three years earlier. On average, white patients were first hospitalized ...

Study detects multidrug-resistant KPC-producing bacteria in Chilean wastewater for the first time

2025-09-01
A team of Chilean researchers has identified, for the first time in the country, the presence of KPC-type carbapenemase-producing bacteria in wastewater samples from the Greater Concepción Metropolitan Area. The finding, published in the journal Biological Research, raises concerns about the environmental circulation of microorganisms with high levels of resistance to critical clinically used antibiotics and reinforces the need for surveillance within the framework of "One Health." The research, which was part of Franco Ilabaca's Master's thesis in Microbiology, was led by Dr. ...

New artificial intelligence model accurately identifies which atrial fibrillation patients need blood thinners to prevent stroke

2025-09-01
Conference: “Late Breaking Science” presentation at the European Society of Cardiology - AI driven cardiovascular biomarkers and clinical decisions Title: Graph Neural Network Automation of Anticoagulation Decision-Making Date: Embargo lifts Monday, September 1, 4:00 pm EDT Bottom Line: Mount Sinai researchers developed an AI model to make individualized treatment recommendations for atrial fibrillation (AF) patients—helping clinicians accurately decide whether or not to treat them with anticoagulants (blood thinner medications) to prevent stroke, which is currently the standard treatment course in this patient population. This model presents a completely ...

Safety of factor XI inhibition with abelacimab in atrial fibrillation by kidney function

2025-09-01
About The Study: In this secondary analysis of the AZALEA-TIMI 71 randomized clinical trial, abelacimab consistently reduced the risk of bleeding relative to rivaroxaban irrespective of kidney function. These findings suggest that abelacimab may offer a particularly favorable safety profile among those with chronic kidney disease; however, larger studies are necessary to characterize the efficacy of abelacimab for stroke prevention in atrial fibrillation. Corresponding Author: To contact the corresponding author, Siddharth M. Patel, MD, MPH, email spatel@bwh.harvard.edu.  To access the embargoed study: Visit our For ...

Combination of mini-camera and AI predicts recurrent heart attack

2025-09-01
Measurements with a miniature camera inside the coronary arteries can accurately predict whether someone will suffer a recurrent heart attack. Until now, interpreting these images was so complex that only specialized laboratories could perform it. A new study from Radboud university medical center shows that AI can reliably take over this analysis and rapidly assess arteries for weak spots. A heart attack occurs when a coronary artery, which supplies the heart with blood, is blocked by a blood clot. This can occur when atherosclerosis causes artery narrowing, resulting in the heart receiving too little oxygen. Treatment typically ...

Study Reveals Details of Overactive Immune System in Patients with Chronic Fatigue Syndrome (ME/CFS)

2025-09-01
Patients with chronic fatigue syndrome/myalgic encephalomyelitis (ME/CFS) have heightened innate immune responses to bacteria, viruses and fungi. While these responses are essential to fight infection, they can cause damage when unchecked. Led by researchers at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health with a multicenter team of leading ME/CFS researchers, the new study reveals molecular-level details into the syndrome’s lasting effects on inflammation and immune response that could inform the development of targeted therapeutic interventions to ...

LAST 30 PRESS RELEASES:

Personalized risk messages fail to boost colorectal cancer screening participation

Something from nothing: Physicists model vacuum tunnelling in a 2D superfluid

CRISPR’s efficiency triples with DNA-wrapped nanoparticles

For the first time in 40 Years, Panama’s deep and cold ocean waters failed to emerge, possibly affecting fisheries and coral health

Depression may make learning to avoid unpleasant events harder

Study sheds light on how pediatric brain tumors grow

Rare seasonal brain shrinkage in shrews is driven by water loss, not cell death

AI co-pilot boosts noninvasive brain-computer interface by interpreting user intent

Black adults face heart failure nearly 14 years earlier than white patients

Study detects multidrug-resistant KPC-producing bacteria in Chilean wastewater for the first time

New artificial intelligence model accurately identifies which atrial fibrillation patients need blood thinners to prevent stroke

Safety of factor XI inhibition with abelacimab in atrial fibrillation by kidney function

Combination of mini-camera and AI predicts recurrent heart attack

Study Reveals Details of Overactive Immune System in Patients with Chronic Fatigue Syndrome (ME/CFS)

UTSA and UT Health San Antonio complete merger to become The University of Texas at San Antonio

Helicobacter pylori screening after acute myocardial infarction

Solar Orbiter traces superfast electrons back to Sun

GaN-based electron beam technology from Nagoya University startup poised to overcome critical semiconductor manufacturing challenges at KIOXIA

Circle versus rectangle: Finding ‘Earth 2.0’ may be easier using a new telescope shape

Metformin changes blood metal levels in humans

Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation

Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease

Participation of women in cardiovascular trials from 2017 to 2023

Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction

Changes in biology of internal fat may be the leading cause of heart failure

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

[Press-News.org] For the first time in 40 Years, Panama’s deep and cold ocean waters failed to emerge, possibly affecting fisheries and coral health